QQ客服 官方微博 反馈留言

	Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D-3 receptor agonists
	Cao, Yongkai[1,2,3,4]; Sun, Ningning[2,3]; Zhang, Jiumei[4]; Liu, Zhiguo[5]; Tang, Yi-zhe[4]; Wu, Zhengzhi[4]; Kim, Kyeong-Man[2,3]; Cheon, Seung Hoon[2,3]
	2018
卷号	9期号:9页码:1457
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4632831
专题	暨南大学
作者单位	1.[1]Jinan Univ, Integrated Chinese & Western Med Postdoctoral Res, Guangzhou 510632, Guangdong, Peoples R China 2.[2]Chonnam Natl Univ, Coll Pharm, Gwangju 500757, South Korea 3.[3]Chonnam Natl Univ, Res Inst Drug Dev, Gwangju 500757, South Korea 4.[4]Shenzhen Univ, Affiliated Hosp 1, Shenzhen 518035, Peoples R China 5.[5]Wenzhou Med Univ, Chem Biol Res Sch Pharmaceut Sci, Wenzhou 325035, Peoples R China
推荐引用方式 GB/T 7714	Cao, Yongkai[1,2,3,4],Sun, Ningning[2,3],Zhang, Jiumei[4],et al. Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D-3 receptor agonists[J],2018,9(9):1457.
APA	Cao, Yongkai[1,2,3,4].,Sun, Ningning[2,3].,Zhang, Jiumei[4].,Liu, Zhiguo[5].,Tang, Yi-zhe[4].,...&Cheon, Seung Hoon[2,3].(2018).Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D-3 receptor agonists.,9(9),1457.
MLA	Cao, Yongkai[1,2,3,4],et al."Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D-3 receptor agonists".9.9(2018):1457.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。